Contact
Please use this form to send email to PR contact of this press release:
SEngine Precision Medicine to Present Data Related to the Predictive Value of PARIS® Test, an Organoid-based Drug Response Assay, for Cholangiocarcinoma Patients at 2020 AACR Virtual Meeting Session II
TO: